August 21, 2014 6:20 PM ET

Biotechnology

Company Overview of IMI International Medical Innovations, Inc.

Company Overview

IMI International Medical Innovations, LLC, doing business as Procris Pharmaceuticals, is a biotech company involved in discovering, developing, and marketing drugs to treat diabetes pain, cancer and anti-infective and neurological diseases. The company was incorporated in 1991 and is based in Birmingham, Alabama.

2871 Acton Road

Suite 100

Birmingham, AL 35243

United States

Founded in 1991

Phone:

205-503-5960

Key Executives for IMI International Medical Innovations, Inc.

IMI International Medical Innovations, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Aviva Systems Biology LLC United States
Apollo Biotechnology, Inc. United States
Target Cancer Therapy, Inc. United States
TGG Medical Transitory, Inc. United States
Antria, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMI International Medical Innovations, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.